Pharmaceutical Companies in Puerto Rico Work Together to Better Understand Federal Regulations on Electronic Records
Schneider Electric Hosts 2-Day Forum for Plant Professionals
SAN JUAN, Puerto Rico, June 3 /PRNewswire/ -- Complying with stringent federal requirements for electronic record-keeping in pharmaceutical plants extends beyond the factory floor to include environmental and utility systems, according to experts at the PharmRx 2002 Regulatory Compliance Forum. Sponsored by Schneider Electric and Intellution, two of the world's largest suppliers of industrial equipment and software for industry, and FDA- compliance expert Stelex, Inc., the forum was attended by more than 100 manufacturing professionals from Puerto Rico's more than 50 pharmaceutical plants. The island is a major manufacturing center for pharmaceutical companies from around the world and attendees included representatives from Merck and Company, Pharmacia, GlaxoSmithKline, Fluor, Lilly, Pfizer, Wyeth, Bristol-Myers Squibb, Abbott, Searle, and AstraZeneca. Experts discussed the impact of the FDA's 21CFR part 11 regulations governing electronic records and signatures on the pharmaceutical manufacturing floor, how the regulations are being interpreted and how agencies are enforcing the regulations. As plant systems become more automated the impact of this regulation continues to grow. The regulations are part of the FDA's efforts to assure consistent manufacturing quality in production of pharmaceutical products. "How regulations are interpreted is a moving target in any regulated industry," explains Stephen Larson, Schneider Electric Global Marketing Manager. "This rule dates back to 1997 and yet many of our customers are just now feeling a big impact on their business. The industry has a tremendous need to keep up to date on how regulations are being interpreted, and how those interpretations impact the manufacturing process." "To hear from many different sources of information at one event is very valuable in understanding the complexities of the new electronic record- keeping guidelines and what it means to our plants," said Grant McDonald, Senior Electrical Engineer, Pfizer, Inc. "Not only is this a critical issue for our industry, but it also presents a new opportunity to further improve manufacturing practices." An international management team with deep pharmaceutical industry experience was formed in 2001 by Schneider Electric to oversee the company's global pharmaceutical initiatives, which include solutions to simplify regulatory compliance, equipment validation and asset management. Schneider Electric is a world leader in electrical distribution, industrial control and automation products and services, integrating a powerful family of brand names -- MERLIN GERIN(R), MODICON(R), SQUARE D(R) and TELEMECANIQUE(R) -- into a global offering. The company had 2001 sales revenues of nearly $9 billion (U.S.) and employs 61,000 people in 130 countries. Learn more about Schneider Electric at www.schneider-electric.com or www.SquareD.com. MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X14953617
SOURCE Schneider Electric
More by this Source
Schneider Electric Announces Availability of Conext Core XC-NA Inverter in North America
Jul 09, 2013, 12:08 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.